Cargando…

Erratum to the association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987834/ https://www.ncbi.nlm.nih.gov/pubmed/35399237 http://dx.doi.org/10.21037/jtd-2022-02

Ejemplares similares

The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer
por: Jiang, Chenxue, et al.
Publicado: (2021)

Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
Publicado: (2022)

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013)

Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2020)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Recurrence Risk Factors Analysis for Stage I Non-small CellLung Cancer: Erratum
Publicado: (2015)

βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2023)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro [Erratum]
Publicado: (2018)

Erratum to efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Publicado: (2022)

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

Role of surgery in patients with early stage small-cell lung cancer [Erratum]
Publicado: (2019)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma: Erratum
Publicado: (2017)

Erratum to SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway
Publicado: (2022)

Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis: Erratum
Publicado: (2016)

Erratum: Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
por: Sheng, Jin, et al.
Publicado: (2016)

Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum
Publicado: (2016)

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
por: Hu, Xingsheng, et al.
Publicado: (2020)

Erratum: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options
por: Moreno, Antonio José Conde, et al.
Publicado: (2015)

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
Publicado: (2022)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer: Erratum
Publicado: (2016)

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016)

Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity
por: Zhang, Hongye, et al.
Publicado: (2020)

Erratum to evaluation of PD-L1 expression on circulating tumour cells in small cell lung cancer
Publicado: (2022)

Erratum to tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer
Publicado: (2021)

Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
por: Guo, Jiwei, et al.
Publicado: (2021)

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
por: Remon, Jordi, et al.
Publicado: (2017)

Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
por: Wang, Yuxiang, et al.
Publicado: (2019)

miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum
por: Liu, Xiaomin, et al.
Publicado: (2023)

Erratum to “Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox”: [Proc. Jpn. Acad., Ser. B 87, No. 3, 104–113]
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)

Erratum: Association of CDKAL1 Polymorphisms with Early-Onset Atopic Dermatitis in Koreans
por: Heo, Won Il, et al.
Publicado: (2018)

Erratum to: The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
por: Zou, Jin-Guo, et al.
Publicado: (2015)

Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis: Erratum
Publicado: (2017)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis: Erratum
Publicado: (2015)

Prognostic Value of Metastatic N1 Lymph Node Ratio and Angiolymphatic Invasion in Patients With Pathologic Stage IIA Non-Small Cell Lung Cancer: Erratum
Publicado: (2016)

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study
por: Ma, Xiaowen, et al.
Publicado: (2018)

Erratum to: Involvement of toll-like receptor 9 polymorphism in cervical cancer development
por: Roszak, Andrzej, et al.
Publicado: (2012)

Erratum to: Ultrasonographic Characteristics of Mammographically Occult Small Breast Cancer
por: Korpraphong, Pornpim, et al.
Publicado: (2012)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum
por: Zhou, Zaigang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_63mbp6c6tqou6mtdncc39di9rr